EX-16.1 2 acbm_ex161.htm LETTER TO THE SECURITIES acbm_ex161.htm

EXHIBIT 16.1

 

July 1, 2025

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

We have read Item 4.01 of Form 8-K of Acro Biomedical Co., Ltd. dated July 1, 2025. We agree with the statements made concerning our firm contained therein.

 

Yours very truly,

 

/s/ Prager Metis CPAs, LLC

 

Hackensack, New Jersey